Clinical Trial Update: Atomoxetine Treatment for ADHD and Marijuana Dependence [Phase 2]

View source ↗

Summary

Phase 2 results from a clinical trial evaluating atomoxetine for people with ADHD and cannabis use disorder have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Cannabis Use Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Marijuana Abuse, Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED | Results posted: 2012-04-09